Your browser doesn't support javascript.
loading
A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses.
Lindqvist, Richard; Benz, Caroline; Sereikaite, Vita; Maassen, Lars; Laursen, Louise; Jemth, Per; Strømgaard, Kristian; Ivarsson, Ylva; Överby, Anna K.
Afiliação
  • Lindqvist R; Department of Clinical Microbiology, Umeå University, 90185 Umeå, Sweden.
  • Benz C; Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, 90186 Umeå, Sweden.
  • Sereikaite V; Department of Chemistry-BMC, Uppsala University, Box 576, Husargatan 3, 75123 Uppsala, Sweden.
  • Maassen L; Center for Biopharmaceuticals, Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
  • Laursen L; Department of Chemistry-BMC, Uppsala University, Box 576, Husargatan 3, 75123 Uppsala, Sweden.
  • Jemth P; Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, Husargatan 3, 75123 Uppsala, Sweden.
  • Strømgaard K; Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, Husargatan 3, 75123 Uppsala, Sweden.
  • Ivarsson Y; Center for Biopharmaceuticals, Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
  • Överby AK; Department of Chemistry-BMC, Uppsala University, Box 576, Husargatan 3, 75123 Uppsala, Sweden.
Viruses ; 14(10)2022 10 06.
Article em En | MEDLINE | ID: mdl-36298757
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus de RNA / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus de RNA / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article